Nasdaq Moves to Delist Stock After SEC Suspension

Holders of small Nasdaq-listed issuers face reduced liquidity as delisted shares may shift to over-the-counter trading.

Updated on Nov. 5, 2026 in Public Companies

Isometric editorial illustration of a half-lowered steel security gate over an empty concrete doorway, with coins spilling onto the floor, evoking a halted market listing.
Nasdaq said Wednesday it will delist Charming Medical Limited's shares after the SEC suspended trading on November 11, 2025, over alleged social-media price manipulation. AI Illustration. Upload story photo >

Live Poll

Do you trust stock tips you see on social media enough to invest based on them?

Nasdaq has determined to delist Charming Medical Limited's securities after the SEC suspended trading in the company's stock on November 11, 2025, citing potential manipulation through social media recommendations. Trading on Nasdaq is scheduled to be suspended November 9, 2026, unless the company requests an appeal by November 5, 2026, and the shares may later move to over-the-counter markets.

Why it matters

The delisting follows an SEC order that pointed to possible third-party manipulation, not any finding of wrongdoing by the company, which Nasdaq says it has not made. For operators of listed or public-facing small companies, it shows how a regulator can halt trading on a stock whose price was allegedly inflated through social media, leaving shareholders with reduced liquidity.

The record consists of a regulatory filing and an SEC order rather than financial results, so no revenue or share-price comparators are reported. The operative dates are the November 11, 2025 SEC trading suspension, the October 29, 2026 delisting letter, the November 5, 2026 appeal deadline, and the November 9, 2026 scheduled Nasdaq suspension.

The players

Nasdaq Stock Market LLC

Nasdaq operates one of the largest U.S. securities exchanges, and its Listing Qualifications Staff enforces listing standards that determine which companies may trade on the exchange.

U.S. Securities and Exchange Commission

The SEC is the federal regulator of U.S. securities markets, with authority to suspend trading and enforce rules against market manipulation.

Charming Medical Limited

Charming Medical is a Hong Kong-headquartered company operating wellness centers, whose securities are listed on Nasdaq.

The details

Nasdaq relied on Listing Rule IM-5101-4, which allows delisting where potential third-party misconduct has led the SEC to impose a temporary trading suspension, rather than on a finding against the company itself. The SEC order cited manipulation of the securities through social media recommendations by unknown persons designed to artificially inflate price and trading volume. Nasdaq will file a Form 25-NSE with the SEC to remove the securities from listing and registration, and the company states the delisting does not affect its ongoing business operations or financial condition.

Timeline

  1. November 11, 2025: SEC issued an order suspending trading in the company's securities.

  2. October 29, 2026: Nasdaq's delisting determination letter is dated.

  3. November 5, 2026: Deadline for the company to request an appeal of the delisting determination.

  4. November 9, 2026: Scheduled suspension of trading on Nasdaq at the opening of business.

Market Landscape

Nasdaq's use of Listing Rule IM-5101-4 here follows the exchange's established practice of delisting securities that the SEC has suspended, even absent findings against the issuer. The action sits within a broader pattern of U.S. regulators scrutinizing social-media-driven price moves in thinly traded small-cap stocks.

Operators tracking exposure to small listed companies should watch for delisting actions that move a stock to over-the-counter trading, which can reduce liquidity and price discovery. Businesses that hold, lend against, or contract with such issuers may want to review their exposure with qualified counsel or an accountant.

The takeaway

A regulatory trading suspension can trigger exchange delisting even when no wrongdoing by the issuer has been found, so the reason and timing matter as much as the outcome. Operators should calendar the November 5, 2026 appeal deadline if they hold or depend on these securities, and track whether an active over-the-counter market develops afterward.

What happens next

Nasdaq will suspend trading in the company's securities at the opening of business on November 9, 2026, unless the company requests an appeal by November 5, 2026.

Further reading

For more on how listed companies move between exchanges and markets, see the Public Companies section.

More information

Read the SEC order suspending trading in Charming Medical securities for the regulator's stated basis.

Source note: This article includes information reported by The Manila times.

Live Poll

Do you trust stock tips you see on social media enough to invest based on them?